116 results
8-K
EX-99.1
VANI
Vivani Medical Inc
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, long-term drug implants including its lead asset NPM-115 … of once-yearly administration.
Moving forward, Vivani will focus on developing NPM-115 and its emerging pipeline of innovative miniature, long-term drug
8-K
EX-99.2
c7yyli 2q0v7f16hcyja
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
8-K
EX-99.1
1swbu 2jkdsilv
6 Mar 24
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
8:30am
8-K
EX-99.1
wunstltyg9o71ji
5 Mar 24
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
4:21pm
424B5
268ktrk0kqfqmk8y1 dv
5 Mar 24
Prospectus supplement for primary offering
11:31am
8-K
EX-99.2
mrtojlclk7m9b
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
i1j8r
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.2
41hm7mt
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.1
2681k6iokw s6md7
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.1
5iynlpytq2il5tg
18 Sep 23
Regulation FD Disclosure
6:20am
8-K
EX-99.1
mpws0l k03og86uw
28 Aug 23
Entry into a Material Definitive Agreement
5:43pm
8-K
EX-99.1
xnt2ev2fnr2
15 May 23
Results of Operations and Financial Condition
6:49am
8-K
EX-99.2
bw46 bu2fk
15 May 23
Results of Operations and Financial Condition
6:49am